# Edible Garden AG Inc: overview

EDBL · Nasdaq · CIK 1809750 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/edbl.md) · [Financials](/companies/edbl/financials.md) · [Filings](/companies/edbl/filings.md) · [Insiders](/companies/edbl/insiders.md)

Latest reported revenue: [$3.5m](/filings/0001477932-26-005081.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001477932-26-005081).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [2,584](/filings/0001477932-25-008250.md) | [3,872 d](/filings/0001477932-26-001867.md) | [2,718](/filings/0001477932-26-003238.md) | [3,146](/filings/0001477932-26-005081.md) | [2,817](/filings/0001477932-25-008250.md) | [4,129 d](/filings/0001477932-26-001867.md) | [3,341](/filings/0001477932-26-003238.md) | [3,550](/filings/0001477932-26-005081.md) |
| Gross margin | % | [27.1%](/filings/0001477932-25-008250.md) | [0.6% d](/filings/0001477932-26-001867.md) | [3.2%](/filings/0001477932-25-003815.md) | [20.2%](/filings/0001477932-25-005936.md) | [9.7%](/filings/0001477932-25-008250.md) | [(29.0%) d](/filings/0001477932-26-001867.md) | not reported | not reported |
| Operating margin | % | [(57.7%)](/filings/0001477932-25-008250.md) | [(70.8%) d](/filings/0001477932-26-001867.md) | [(107.7%)](/filings/0001477932-26-003238.md) | [(114.2%)](/filings/0001477932-26-005081.md) | [(126.3%)](/filings/0001477932-25-008250.md) | [(138.6%) d](/filings/0001477932-26-001867.md) | [(199.9%)](/filings/0001477932-26-003238.md) | [(89.5%)](/filings/0001477932-26-005081.md) |
| Net margin | % | [(79.8%)](/filings/0001477932-25-008250.md) | [(79.5%) d](/filings/0001477932-26-001867.md) | [(122.3%)](/filings/0001477932-26-003238.md) | [(128.5%)](/filings/0001477932-26-005081.md) | [(143.6%)](/filings/0001477932-25-008250.md) | [94.8% d](/filings/0001477932-26-001867.md) | [(109.8%)](/filings/0001477932-26-003238.md) | [(91.8%)](/filings/0001477932-26-005081.md) |
| Diluted EPS | $ per share | [16.32](/filings/0001477932-25-008250.md) | not reported | [(24.74)](/filings/0001477932-26-003238.md) | [(2960.37)](/filings/0001477932-26-005081.md) | [1.38](/filings/0001477932-25-008250.md) | not reported | [(5.25)](/filings/0001477932-26-003238.md) | [(18.79)](/filings/0001477932-26-005081.md) |
| Free cash flow | $k | [(1,122) d](/filings/0001477932-25-008250.md) | [(1,881) d](/filings/0001477932-26-001867.md) | [(3,411)](/filings/0001477932-26-003238.md) | [(3,486) d](/filings/0001477932-26-005081.md) | [(2,787) d](/filings/0001477932-25-008250.md) | [(2,758) d](/filings/0001477932-26-001867.md) | [147](/filings/0001477932-26-003238.md) | [(2,616) d](/filings/0001477932-26-005081.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [10.5](/filings/0001477932-23-001657.md) | [11.6](/filings/0001477932-24-001638.md) | [14.0](/filings/0001477932-25-002281.md) | [13.9](/filings/0001477932-26-001867.md) | [12.8](/filings/0001477932-26-001867.md) |
| Gross margin | % | [6.2%](/filings/0001477932-23-001657.md) | [3.2%](/filings/0001477932-24-001638.md) | [5.9%](/filings/0001477932-25-002281.md) | [16.7%](/filings/0001477932-26-001867.md) | [(1.6%)](/filings/0001477932-26-001867.md) |
| Operating margin | % | not reported | [(77.9%)](/filings/0001477932-24-001638.md) | [(70.3%)](/filings/0001477932-25-002281.md) | [(66.9%)](/filings/0001477932-26-001867.md) | [(123.3%)](/filings/0001477932-26-001867.md) |
| Net margin | % | [(52.7%)](/filings/0001477932-23-001657.md) | [(107.8%)](/filings/0001477932-24-001638.md) | [(72.5%)](/filings/0001477932-25-002281.md) | [(79.8%)](/filings/0001477932-26-001867.md) | [(135.3%)](/filings/0001477932-26-001867.md) |
| Diluted EPS | $ per share | not reported | not reported | [(1541.79)](/filings/0001477932-25-002281.md) | [(685.62)](/filings/0001477932-26-001867.md) | [(117.64)](/filings/0001477932-26-001867.md) |
| Free cash flow | $m | [(4.2)](/filings/0001477932-23-001657.md) | [(11.2)](/filings/0001477932-24-001638.md) | [(9.6)](/filings/0001477932-25-002281.md) | [(8.8)](/filings/0001477932-26-001867.md) | [(12.4)](/filings/0001477932-26-001867.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues; Operating income: us-gaap:OperatingIncomeLoss.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/edbl/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Sale (S) | 26,335 | $5.3192 | $140.1k | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Sale (S) | 97 | $6.22 | $603.34 | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Sale (S) | 190 | $6.235 | $1.2k | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Sale (S) | 186 | $6.22 | $1.2k | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Sale (S) | 33 | $6.22 | $205.26 | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Sale (S) | 100 | $6.22 | $622 | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Sale (S) | 100 | $6.16 | $616 | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Sale (S) | 14 | $6.16 | $86.24 | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Purchase (P) | 1 | $6.237 | $6.24 | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Sale (S) | 1 | $5.95 | $5.95 | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Purchase (P) | 2 | $5.883 | $11.77 | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Purchase (P) | 1 | $6.28 | $6.28 | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Sale (S) | 3,000 | $6.2485 | $18.7k | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Purchase (P) | 1 | $6.085 | $6.08 | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Purchase (P) | 700 | $6.106 | $4.3k | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-25 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Purchase (P) | 300 | $6.0008 | $1.8k | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-24 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Sale (S) | 105 | $6.30 | $661.50 | [Form 4](/filings/0001610520-24-000090.md) |
| 2024-04-24 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Sale (S) | 1 | $6.20 | $6.20 | [Form 4](/filings/0001610520-24-000090.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BARD ASSOCIATES INC](/funds/1105907.md) | 2026-06-30 | $6.4k | 142,025 |  | Unchanged |
| [Clear Street Group Inc.](/funds/1881567.md) | 2026-06-30 | $761 | 16,959 |  | Added +400 |
| [SBI Securities Co., Ltd.](/funds/1851815.md) | 2026-06-30 | $120 | 628 |  | New +628 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $5 | 100 |  | New +100 |
| [Coston, McIsaac & Partners](/funds/1945037.md) | 2026-06-30 | $0 | 650 |  | Unchanged |

## Recent filings

[All 343 filings](/companies/edbl/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 11:15 ET | [8-K](/filings/0001477932-26-006391.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001477932-26-006391 |
| 2026-10-01 | 20:01 ET | [8-K](/filings/0001477932-26-005955.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-005955 |
| 2026-09-02 | 11:35 ET | [8-K](/filings/0001477932-26-005353.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-005353 |
| 2026-08-24 | 11:45 ET | [8-K](/filings/0001477932-26-005237.md) | 8.01 Other events | 0001477932-26-005237 |
| 2026-08-17 | 19:46 ET | [8-K](/filings/0001477932-26-005129.md) | 5.02 Departure or appointment of officers or directors | 0001477932-26-005129 |
| 2026-08-14 | 20:16 ET | [10-Q](/filings/0001477932-26-005081.md) | Quarterly report, period 2026-06-30 | 0001477932-26-005081 |
| 2026-08-14 | 11:45 ET | [8-K](/filings/0001477932-26-005007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-26-005007 |
| 2026-08-11 | 20:22 ET | [8-K](/filings/0001477932-26-004877.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001477932-26-004877 |
| 2026-08-07 | 20:30 ET | [8-K](/filings/0001477932-26-004776.md) | 3.02 Unregistered sale of equity | 0001477932-26-004776 |
| 2026-08-03 | 12:01 ET | [8-K](/filings/0001477932-26-004660.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-004660 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001477932-26-001867.md), filed Mar 31, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/d384b82a-772b-4a0d-b13d-8592c82d5254)

## About the filer

- CIK: 1809750
- Tickers: EDBL, EDBLW
- Exchange: Nasdaq
- SIC code: 100 Agricultural Production-Crops
- State of incorporation: DE
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.
